Rafael Alonso Fernández

10PUBLICATIONS
99CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

|Dec 11, 2025
Real-world evidence of measurable residual disease assessment in multiple myeloma.

Maria-Teresa Cedena, Noemi Puig, Bruno Paiva

|Nov 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Roberto García-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|Dec 18, 2023
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma.

Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente

|May 19, 2023
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study.

Rosa Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez

Pageof 2

Frequent Collaborators

5 joint publications

Joaquín Martínez-López

4 joint publications

Noemí Puig

3 joint publications

María-Teresa Cedena

3 joint publications

José Sánchez-Pina